Smithfield Trust’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-138
Closed -$10K 1108
2020
Q4
$10K Hold
138
﹤0.01% 813
2020
Q3
$7K Hold
138
﹤0.01% 851
2020
Q2
$7K Hold
138
﹤0.01% 800
2020
Q1
$5K Sell
138
-31
-18% -$1.81K ﹤0.01% 778
2019
Q4
$15K Hold
169
﹤0.01% 655
2019
Q3
$15K Hold
169
﹤0.01% 686
2019
Q2
$18K Hold
169
﹤0.01% 645
2019
Q1
$18K Hold
169
﹤0.01% 601
2018
Q4
$15K Hold
169
﹤0.01% 607
2018
Q3
$17K Sell
169
-228
-57% -$22K ﹤0.01% 662
2018
Q2
$33K Hold
397
﹤0.01% 594
2018
Q1
$29K Hold
397
﹤0.01% 593
2017
Q4
$28K Buy
397
+31
+8% +$2.24K ﹤0.01% 617
2017
Q3
$23K Sell
366
-4,472
-92% -$265K ﹤0.01% 635
2017
Q2
$278K Sell
4,838
-1,163
-19% -$68.4K 0.04% 225
2017
Q1
$365K Buy
+6,001
New +$339K 0.06% 185

Other funds holding NGVT

Smithfield Trust's NGVT Position: Q1 2021 in Review

Smithfield Trust sold out of Ingevity (NGVT) in Q1 2021, closing a stake of 138 shares — an estimated $10K sold.

Smithfield Trust first reported a position in NGVT in Q1 2017 and held it in 16 quarters. The position peaked at $365K in Q1 2017. 286 funds tracked by Wall St. Rank hold NGVT as of Q1 2021.

  • Smithfield Trust reported no remaining Ingevity position as of Q1 2021 after selling out during the quarter.
  • Smithfield Trust sold 138 Ingevity shares in Q1 2021, an estimated $10K.
  • Smithfield Trust first reported a position in Ingevity in Q1 2017 and held it in 16 quarters.
  • Smithfield Trust's Ingevity position peaked at $365K in Q1 2017.
  • 286 funds tracked by Wall St. Rank held Ingevity as of Q1 2021.

Based on Smithfield Trust's 13F filing for Q1 2021, filed 14 May 2021.